128 related articles for article (PubMed ID: 3327159)
1. Ceftazidime treatment in severe burns. Serious infections in patients with severe burns treated with ceftazidime.
Kunst MW
Scand J Plast Reconstr Surg Hand Surg; 1987; 21(3):281-2. PubMed ID: 3327159
[TBL] [Abstract][Full Text] [Related]
2. Ceftazidime therapy versus aminoglycoside therapy in patients with gram-negative burn wound infections.
Stiver HG; Goldring AM; Snelling CF; Ronald AR; Robertson GA; Goldsand G; Dawson L
J Burn Care Rehabil; 1987; 8(1):19-22. PubMed ID: 3553200
[No Abstract] [Full Text] [Related]
3. [Clinical results of Fortum and Zinacef trial in Burn Centers of Russia].
Alekseev AA; Krutikov MG; Smirnov SV; Malakhov SF; Filimonov AA
Khirurgiia (Mosk); 1996; (5):55-9. PubMed ID: 9011659
[No Abstract] [Full Text] [Related]
4. [Ceftazidime in severe infections in burnt patients].
Dhennin C; Vesin L; Feauveaux JF; Berdalle JP
Presse Med; 1988 Oct; 17(37):1940-3. PubMed ID: 2973591
[TBL] [Abstract][Full Text] [Related]
5. Ceftazidime in the therapy of serious Gram-negative bacillary infections.
Pottage JC; Karakusis PH; Fliegelman RM; Levin S; Trenholme GM
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():223-8. PubMed ID: 6352623
[TBL] [Abstract][Full Text] [Related]
6. Potential of combination therapy of endolysin MR-10 and minocycline in treating MRSA induced systemic and localized burn wound infections in mice.
Chopra S; Harjai K; Chhibber S
Int J Med Microbiol; 2016 Dec; 306(8):707-716. PubMed ID: 27616281
[TBL] [Abstract][Full Text] [Related]
7. The impact of the types of microorganisms isolated from blood and wounds on the results of treatment in burn patients with sepsis.
Glik J; Kawecki M; Gaździk T; Nowak M
Pol Przegl Chir; 2012 Jan; 84(1):6-16. PubMed ID: 22472489
[TBL] [Abstract][Full Text] [Related]
8. Locally delivered antibodies combined with systemic antibiotics confer synergistic protection against antibiotic-resistant burn wound infection.
Felts AG; Grainger DW; Slunt JB
J Trauma; 2000 Nov; 49(5):873-8. PubMed ID: 11086779
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and bacteriologic effectiveness of ceftazidime in infections with gram-positive pathogens].
Tolxdorff-Neutzling R; Klages G; Danner H
Infection; 1987; 15 Suppl 4():S195-9. PubMed ID: 3312034
[TBL] [Abstract][Full Text] [Related]
10. Ceftazidime--a new extended-spectrum cephalosporin.
Gozzard DI; Geddes AM; Farrell ID; Eykyn SJ; Phillips I; Wise R; Brown RM
Lancet; 1982 May; 1(8282):1152-6. PubMed ID: 6122940
[TBL] [Abstract][Full Text] [Related]
11. Netilmicin. A new aminoglycoside in the treatment of septic burn patients.
Munster AM
Arch Surg; 1979 Jan; 114(1):28-30. PubMed ID: 758874
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intravenous ciprofloxacin with ceftazidime in the treatment of serious soft tissue infections.
Tice AD; Marsh PK; Craven PC
Diagn Microbiol Infect Dis; 1990; 13(2):165-7. PubMed ID: 2196153
[No Abstract] [Full Text] [Related]
13. Nanoemulsion Therapy for Burn Wounds Is Effective as a Topical Antimicrobial Against Gram-Negative and Gram-Positive Bacteria.
Dolgachev VA; Ciotti SM; Eisma R; Gracon S; Wilkinson JE; Baker JR; Hemmila MR
J Burn Care Res; 2016; 37(2):e104-14. PubMed ID: 26182074
[TBL] [Abstract][Full Text] [Related]
14. Ceftazidime in neonatal infections.
Low DC; Bissenden JG; Wise R
Arch Dis Child; 1985 Apr; 60(4):360-4. PubMed ID: 3890766
[TBL] [Abstract][Full Text] [Related]
15. Open study of ceftazidime in serious infections due to multiply-resistant bacteria.
Pechère JC; Delisle R
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():181-8. PubMed ID: 6352619
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of ceftazidime in the treatment of severe bacterial infection.
Bouza E; Hellín T; Sanz-Hospital J; Rodríguez-Creixems M; Loza E; Martínez-Beltrán J
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():153-9. PubMed ID: 6352616
[TBL] [Abstract][Full Text] [Related]
17. Management and prevention of drug resistant infections in burn patients.
Vinaik R; Barayan D; Shahrokhi S; Jeschke MG
Expert Rev Anti Infect Ther; 2019 Aug; 17(8):607-619. PubMed ID: 31353976
[No Abstract] [Full Text] [Related]
18. Cephalosporins in cutaneous infections. A prospective comparison of two dosage regimens of ceftazidime for therapy of skin and skin structure infections.
Parish LC; Witkowski JA; Snow R; Eron L; Mogabgab WJ
Int J Dermatol; 1986 May; 25(4):258-65. PubMed ID: 3519482
[TBL] [Abstract][Full Text] [Related]
19. Tigecycline accelerates staphylococcal-infected burn wound healing through matrix metalloproteinase-9 modulation.
Simonetti O; Cirioni O; Lucarini G; Orlando F; Ghiselli R; Silvestri C; Brescini L; Rocchi M; Provinciali M; Guerrieri M; Di Primio R; Giacometti A; Offidani A
J Antimicrob Chemother; 2012 Jan; 67(1):191-201. PubMed ID: 22065244
[TBL] [Abstract][Full Text] [Related]
20. A comparison of ceftazidime and aminoglycoside based regimens as empirical treatment in 1316 cases of suspected sepsis in the newborn. European Society for Paediatric Infectious Diseases--Neonatal Sepsis Study Group.
de Louvois J; Dagan R; Tessin I
Eur J Pediatr; 1992 Dec; 151(12):876-84. PubMed ID: 1473540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
